EXP2481- PUR7776_BPHL_BioGX - FINAL.pdf

PUR 7776 (Eff. 03/2016) Page 1 of 2 60A-1.045, F.A.C.

DESCRIPTION OF INTENDED

SINGLE SOURCE PURCHASE

(PUR 7776)

AGENCY: Florida Department of Health (FDOH)

TITLE: BioGX Mycobacterium Tuberculosis Complex SPC Short description of the commodity or service desired: Sample-Ready™ custom mixed and lyophilized PCR reagents for testing Mycobacterium Tuberculosis Complex

CONTACT:

Name: Katrina Ferguson Address: 4052 Bald Cypress Way, Tallahassee, FL 32399 Telephone: 850-617-5854 Email: Katrina.Ferguson@flhealth.gov

Internal tracking number, if any: EXP2481

Date posted:09/13/22 @ 5:00 pm Last day for receipt of information:10/04/22 @ 5:00 pm

This description of commodities or contractual services intended for purchase from a single source is posted in accordance with sections 120.57(3) and 287.057(3), Florida Statutes (F.S), and will remain posted for a period of at least 15 business days.

Commodity or Contractual Service Required (commodity or United National Standard Products and Services Code (UNSPSC), manufacturer, model, and description, as appropriate):

12161500 Indicators and Reagents 41116000 Clinical and diagnostic analyzer reagents

Quantity or Term (as appropriate):

3years

Requestor (division, bureau, office, individual, as appropriate):

FDOH, Division of Disease Control and Health Protection, Bureau of Public Health Laboratories

(BPHL)

Performance and/or Design Requirements (e.g. intended use, function or application, compatibility, requirements; reference to policy, rule, statute or other act of the Legislature, etc., as appropriate):

The FDOH, BPHL has a need to purchase custom mixed and lyophilized PCR reagents compatible with the existing instrumentation system and test algorithm used by the BPHL TB section for the mailto:Katrina.Ferguson@flhealth.gov

PUR 7776 (Eff. 03/2016) Page 2 of 2 60A-1.045, F.A.C.

rapid detection of MTB (Mycobacterium tuberculosis) complex. Service includes custom mixing of customer-specified reagents (oligos) with PCR Master-mix components, and lyophilization in single tube snap-in reagent configuration in BD MAX position 3 tubes. Reagents must be compatible with use on the BD Max platform.

In accordance with 60A-1.045 Florida Administrative Code, the FDOH BPHL requests authorization to purchase, as a single source, BioGX Mycobacterium Tuberculosis Complex SPC.

Intended Single Source:

BioGX

Estimated Dollar Amount:

$290,000.00

Justification for single source acquisition (what is necessary and unique about the product, service or source; steps taken to confirm unavailability of competition, as appropriate):

• The BioGX Mycobacterium Tuberculosis Complex SPC is the only product with a custom mix that is compatible with the existing instrumentation system (BD Max platform) and test algorithm currently in use at BPHL.

• BioGX is the sole distributor/manufacturer of the Mycobacterium Tuberculosis Complex

SPC.

Approved By (names & titles, as appropriate, e.g., requestor, requestor management, information systems, budget, purchasing):

Samantha Washington, Chief, Bureau of General Services

Prospective vendors are requested to provide information regarding their ability to supply the commodities or contractual services described. If it is determined in writing by the agency, after reviewing any information received from prospective vendors, that the commodities or contractual services are available only from a single source, the agency shall: provide notice of its intended decision to enter a single-source purchase contract in the manner specified in Rule 60A-1.045, Florida Administrative Code, and section 120.57(3), FS.